“The Report EpiCast Report: Cystic Fibrosis – Epidemiology Forecast to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”
Cystic fibrosis (CF) is an inherited disorder that affects the cells that produce mucus, sweat, and digestive juices, causing severe damage to the lungs, digestive system, and other organs. In CF patients, a defective gene results in sticky and thick secretions that plug up tubes, ducts, and passageways. The signs and symptoms of CF vary depending on the severity of the disease. Most of the signs and symptoms of CF affect the respiratory system and digestive system.
GlobalData epidemiologists provided two different forecasts for the diagnosed incident and diagnosed prevalent cases of CF in the 7MM: a forecast based on registry data and a forecast adjusted for the underestimation of registry-based data. According to the forecast based on registry data, the diagnosed incident cases of CF in the 7MM will decrease from 1,925 cases in 2015 to 1,813 cases in 2025, at an Annual Growth Rate (AGR) of negative 0.58%. The US will have the highest number of diagnosed incident cases of CF among the 7MM throughout the forecast period, while Germany will have the lowest.
According to the forecast adjusted for underestimation of registry data, the diagnosed incident cases of CF in the 7MM will decrease from 2,217 cases in 2015 to 2,074 cases in 2025, at an AGR of negative 0.64%. The US will have the highest number of diagnosed incident cases of CF among the 7MM throughout the forecast period, while Germany will have the lowest.
Get Sample Copy Of This Report @
GlobalData epidemiologists utilized peer-reviewed, country-specific studies to forecast diagnosed incident cases, diagnosed prevalent cases, and mortality due to CF in the 7MM from 2015-2025. Diagnosed prevalent cases were segmented by sex, age, specific mutation type, and MRSA infection to provide more detailed information about the patient population. GlobalData epidemiologists ensured that the forecast methodology was consistent across all the 7MM to allow for a meaningful comparison of CF across these markets.
View Report @ http://www.marketresearchreports.biz/analysis/1068076
Reasons to buy
The CF EpiCast series will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global CF market.
– Quantify patient populations in the global CF market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CF therapeutics in each of the markets covered.
– Identify the percentage of CF diagnosed prevalent cases by age, sex, specific mutation type, and MRSA infection.
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207